What is Arvee Laboratories (India) Ltd (ARVEE) share price return in the past 10 years?

Data is not available for this company

What is the share price of Arvee Laboratories (India) Ltd (ARVEE)?

Company share prices are keep on changing according to the market conditions. The current trading price of Arvee Laboratories (India) Ltd (ARVEE) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Arvee Laboratories (India)?

The latest standalone P/E ratio of Arvee Laboratories (India) as of 01-Jan-1970 is 74.30.

What is the P/B ratio of Arvee Laboratories (India) Ltd (ARVEE)?

The latest standalone P/B ratio of Arvee Laboratories (India) Ltd (ARVEE) as of 01-Jan-1970 is 5.55.

What is the 52-week high and low of Arvee Laboratories (India) Ltd (ARVEE)?

The 52-week high of Arvee Laboratories (India) Ltd (ARVEE) is Rs. 0.00 and the 52-week low is Rs. 0.00.

Arvee Laboratories (India) Ltd (ARVEE) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Arvee Laboratories (India) Ltd (ARVEE)
Brand: Arvee Laboratories (India)

Key Metrics

Valuation Multiples

Market Cap

₹188 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹2.3

TTM Sales

₹31.5 Cr.

Book Value per Share

₹30.7

P/E Ratio

74.30

In line with its 5-year historical median

Industry PE

49.1

Price to Book (P/B)

5.55

Higher than its 5-year historical median

Price to Sales (P/S)

5.95

Higher than its 5-year historical median

EV/EBITDA

47.82

Higher than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

7.11%

Underperforms industry median

Return on Capital Employed (ROCE)

10.00%

Underperforms industry median

Return on Assets (ROA)

5.64%

Operating Profit Margin

9.4%

Net Profit Margin

5.58%

Gross Profit Margin

10.4%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

26.82%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

22.79%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

104.76%

Asset Quality

Promoter Holding

73.50%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹23 Cr.

Equity

₹11 Cr.

Face Value

₹10

All Time Low / High

- / -

Arvee Laboratories (India) stock performance

Key Ratios

Check Before You Invest

Quality

Very Good

Check detailed performance

Valuation

Somewhat Overvalued

Check Valuation charts

Price Trend

Strong

Check Price chart

Q.1 Is Arvee Laboratories (India) Ltd a good quality company?

Arvee Laboratories (India) Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Arvee Laboratories (India) Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Arvee Laboratories (India) Ltd vs industry peers?

Arvee Laboratories (India) Ltd revenue CAGR is -3.26%, compared to the industry median CAGR of 7.53%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Arvee Laboratories (India) Ltd?

Promoters hold 73.50% of the Arvee Laboratories (India) Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Arvee Laboratories (India) Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of 1.24% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	14.4%	15.2%	17.7%	14.1%	15.8%	16%	13.3%	23.4%	7%	10%	-
Value Creation Index ⓘ	0.0	0.1	0.3	0.0	0.1	0.1	-0.1	0.7	-0.5	-0.3	-
Growth Parameters ⓘ
Sales ⓘ	26.8	34.4	47.8	54.9	45.4	47.4	40.3	61.4	30.4	38.5	32
Sales YoY Gr.	-	28.3%	38.8%	14.9%	-17.3%	4.3%	-14.9%	52.1%	-50.5%	26.8%	-
Adj EPS ⓘ	0.2	1.9	1	2.1	2	2.5	2.3	3	0.9	1.9	2.3
YoY Gr.	-	734.8%	-48.4%	107.1%	-4.4%	25%	-6.5%	31.9%	-71.5%	118.6%	-
BVPS (₹) ⓘ	3.3	5.2	12.7	14.8	16.9	19.4	21.7	25.5	26.4	28.4	30.7
Adj Net Profit ⓘ	0.2	1.6	1.1	2.3	2.2	2.7	2.5	3.3	1	2.1	3
Cash Flow from Ops. ⓘ	6.2	4	6	9.5	10.3	1.7	4	2.9	3.7	-0.2	-
Debt/CF from Ops. ⓘ	4.1	6.2	2.7	1.4	0.4	5.2	0.8	0.3	0.3	-5	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	4.1%	-3.3%	-1.5%	26.8%
Adj EPS ⓘ	26.3%	-0.8%	-6.4%	118.6%
BVPSⓘ	27.2%	10.9%	9.3%	7.4%
Share Price	-	8%	18%	-2.9%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	9.2	45.4	11.8	14.8	12.2	13.4	11.1	12.8	3.3	6.9	7.8
Op. Profit Mgn % ⓘ	17.5	16.3	15	11.3	13.3	12.8	14	11.9	9.7	9.4	10.1
Net Profit Mgn % ⓘ	0.7	4.5	2.3	4.1	4.7	5.7	6.3	5.4	3.1	5.4	8
Debt to Equity ⓘ	9.6	6	1.2	0.8	0.2	0.4	0.1	0	0	0	0
Working Cap Days ⓘ	187	182	167	140	124	123	167	127	271	181	210
Cash Conv. Cycle ⓘ	70	83	64	53	33	25	53	43	85	66	149

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	27	34	48	55	45	47	40	61	30	38
Operating Expenses ⓘ +	22	29	41	49	39	41	35	54	27	35
Manufacturing Costs	2	3	5	4	3	3	3	5	4	4
Material Costs	17	22	30	39	29	29	22	39	15	21
Employee Cost	2	3	3	3	3	6	6	6	6	7
Other Costs ⓘ	1	1	3	3	4	3	3	4	3	3
Operating Profit ⓘ	5	6	7	6	6	6	6	7	3	4
Operating Profit Margin (%)	17.5%	16.3%	15.0%	11.2%	13.3%	12.7%	13.9%	11.9%	9.7%	9.4%
Other Income ⓘ +	0	1	0	0	0	1	1	1	1	1
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	3	3	3	2	1	1	0	0	0	0
Depreciation ⓘ	1	2	2	2	2	2	2	2	1	1
Profit Before Tax ⓘ	1	1	2	3	3	4	3	6	2	3
Tax ⓘ	0	-1	1	0	1	1	1	2	1	1
Profit After Tax	0	2	1	2	2	3	3	4	1	2
PAT Margin (%)	0.7%	4.5%	2.3%	4.1%	5.1%	5.7%	6.4%	6.7%	3.5%	5.6%
Adjusted EPS (₹)	0.2	1.9	1.0	2.1	2.1	2.4	2.3	3.7	1.0	2.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Arvee Laboratories - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	3	4	14	16	19	21	24	28	29	31
Share Capital ⓘ	4	4	6	6	6	11	11	11	11	11
Reserves ⓘ	-1	0	9	11	13	10	13	17	18	20
Debt +	24	24	15	11	4	9	3	1	1	1
Long Term Debt	17	17	8	3	2	1	1	1	1	1
Short Term Debt	6	7	7	8	2	8	2	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	6	6	12	6	10	10	10	8	7	3
Others Liabilities ⓘ	3	2	3	3	1	1	2	2	2	2
Total Liabilities ⓘ	35	36	44	37	34	41	39	39	39	38
Fixed Assets
Net Fixed Assets ⓘ +	13	17	15	13	13	14	14	13	13	15
Gross Block	16	21	22	22	24	27	30	31	32	36
Accumulated Depreciation	2	4	7	9	11	14	16	18	20	21
CWIP ⓘ	4	0	1	2	2	1	1	2	3	1
Investments ⓘ	0	0	0	2	3	2	0	0	0	0
Inventories	7	6	8	5	6	7	6	5	6	5
Trade Receivables	6	8	15	8	7	8	12	12	6	8
Cash Equivalents	1	1	2	4	1	7	5	1	2	5
Others Assets ⓘ	3	3	2	4	2	2	1	7	9	4
Total Assets ⓘ	35	36	44	37	34	41	39	39	39	38

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	6	4	6	9	10	2	4	3	4	-0
PBT ⓘ	1	1	2	3	3	4	3	6	2	3
Adjustment ⓘ	4	5	5	3	3	2	2	2	1	1
Changes in Working Capital ⓘ	1	-3	-1	4	5	-3	-1	-4	1	-3
Tax Paid ⓘ	0	1	-1	-0	-1	-1	-1	-2	-0	-1
Cash Flow From Investing Activity ⓘ +	-5	-1	-1	-3	-3	-1	0	-1	-2	-1
Capex	-5	-1	-1	-2	-2	-2	-2	-1	-3	-2
Net Investments	0	0	0	-2	-1	1	2	0	0	0
Others ⓘ	0	0	0	1	0	1	0	0	0	0
Cash Flow From Financing Activity ⓘ +	-1	-3	-4	-5	-10	5	-6	-2	-0	-0
Net Proceeds from Shares ⓘ	1	0	9	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	3	-9	-4	0	-1	-6	-2	0	0
Interest Paid ⓘ	-3	-3	-3	-1	-1	-0	-0	-0	-0	-0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	1	-3	-1	1	-9	6	-0	0	0	0
Net Cash Flow ⓘ	0	-0	1	2	-3	6	-2	-1	1	-2

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	9.24	45.41	12.01	14.97	13.17	13.38	11.36	15.84	3.68	7.11
ROCE (%)	14.39	15.19	17.69	14.1	15.79	15.99	13.33	23.35	7.03	10
Asset Turnover Ratio	0.88	0.97	1.2	1.35	1.28	1.27	1.01	1.59	0.79	1.01
PAT to CFO Conversion(x)	N/A	2	6	4.5	5	0.67	1.33	0.75	4	-0
Working Capital Days
Receivable Days	52.10	75.80	90.50	77.80	58	55.50	90.60	72.60	110.50	68.80
Inventory Days	91.40	70.50	54.90	42.40	44.50	53.50	59.60	30.60	65.90	51.90
Payable Days	96.90	99.10	110.70	85.10	100.40	121.20	157.70	82.20	180.60	87.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Arvee Laboratories (India) Ltd FAQs

The current trading price of Arvee Laboratories on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Arvee Laboratories stood at ₹187.6 Cr

The latest P/E ratio of Arvee Laboratories as of 31-Dec-1969 is 74.30.

The latest P/B ratio of Arvee Laboratories as of 31-Dec-1969 is 5.55.

The 52-week high of Arvee Laboratories is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Arvee Laboratories is ₹31.51 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Arvee Laboratories (India) Ltd is a good quality company.

The key valuation ratios of Arvee Laboratories (India) Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Arvee Laboratories (India) Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Arvee Laboratories (India) Ltd

Arvee Laboratories (India) (Arvee) started its operations with an aim to become a leader & frontrunner in chemical industry by providing the best and innovative quality chemical products. The company intended to establish eco-friendly organization dedicated to providing good quality innovative products at very competitive price. Keeping quality and precision as the benchmark for any operation, Arvee hails to become the most sought-after chemical manufacturing company offering best products at very reasonable price. Quality, Service and Advancement are the mainstay of the company which has brought it this far in the chemical industry. From humble beginnings, Arvee has carved a remarkable presence in the chemical industry in a very short span.

Ever since inception, quality has been a constant and guiding factor in every practice at Arvee. More than a practice it is a pledge taken by each and every member of its team to stay committed and true to the highest quality standards. This enables the company to manufacture best quality products while taking care of safekeeping the environment and personnel. Over the years, its commitment to maintaining high quality standards in an eco-friendly way has helped it to build long-lasting and rewarding relationships with its clients. As part of the quality policy, every process and practice at Arvee is committed to greater cause of keeping the environment safe and sustainable.

The company was incorporated as ‘Arvee Laboratories (India) Private Limited’ under the provisions of the Companies Act, 1956 vide certificate of incorporation dated January 27, 2012 in Ahmedabad, Gujarat. Subsequently, the name of the company was changed to ‘Arvee Laboratories (India) Limited’ pursuant to shareholder’s resolution on September 11, 2017 and vide fresh certificate of incorporation dated September 19, 2017.

Business area of the company

Arvee is engaged in manufacturing of specialized chemicals. The plant facilities and other utility services at Arvee are equipped to undertake a host of processes namely, Nitration, Sulfonation, Reduction, Halogenation, Esterification, Alkylation, Acylation, Hoffman Reaction, Grignard Reaction, Vilsmeyer Heack Reaction, Sandmeyer Reaction, Caustic Fusion, Friedel-Crafts Reaction and Catalytic Reduction. The company caters to the demand of both domestic as well as international markets.

Products

Polymer Modifiers

Dimethyl 5-Sodiosulfoisophthalate
5-Sulfoisophthalic Acid Mono Sodium Salt
5-Sulfoisophthalic Acid Mono Lithium Salt
5-Sodiosulfo-Bis-(Î²-Hydroxyethyl)-Isophthalate

Contrast Media Intermediates

5-Nitroisophthalic acid
Dimethyl 5-Nitroisophthalate
Monomethyl 5-Nitroisophthalate
5-Hydroxyisophthalic acid
5-Aminoisophthalic acid
Dimethyl 5-Aminoisophthalate
3,5-Dinitrobenzoic Acid
3,5-Diamino Benzoic Acid

Drug Intermediates

2-Acetyl Thiophene
Thiophene-2-Carboxaldehyde
4-Amino Pyridine
2-Chloro-5-nitrobenzoic acid

Major Events and Milestones:

2012: The company was incorporated as Arvee Laboratories (India) Private Limited.
2013: Acquired land, building and machineries from Skylink Chemicals Private Limited and started manufacturing unit.
2013: Started construction of its first plant for Thiophene Derivatives.
2013: Completes construction and commissioning of its Thiophene Derivatives Plant.
2014: Plant inspected and approved by leading India pharmaceutical manufacturer for supply of Thiophene Derivatives.
2014: Started construction of plant for Sulfo and Nitro Derivatives of Isophthalic Acid.
2014: Received ISO 9001:2008 accreditation for NABCB and DAKKS from TUV NORD.
2014: Plant inspected and approved by an American X-Ray Contrast Media manufacturer and started pilot trials with the manufacturer.
2014: Plant inspected and approved by a European X-Ray Contrast Media manufacturer and started pilot trials with the manufacturer.
2015: Completed construction and commissioning of plant for Nitro Derivatives of Isophthalic Acid.
2015: After receiving inspection approval, the Company gets order for yearly supply of Nitro Derivatives of Isophthalic Acid to leading contrast media manufacturer in the United States of America.
2015: Export to United States of America (USA) started.
2015: Plant inspected and approved by European manufacturer for supply of Thiophene Derivatives.
2015: Export of Thiophene Derivatives started to Europe.
2016: Receives internal approvals for their Nitro Derivatives of Isophthalic acid from leading X- Ray contrast media manufacturer in Europe.
2016: Receive approval for the Sulfo Derivatives of Isophthalic acid from a large polymer manufacturer in the United States of America and received yearly order for supply of Sulfo Derivatives to the USA.
2016: Crossed turnover of Rs 25 crores.
2017: Plant inspected and approved by an American X-ray contrast media manufacturer who has the largest market share in the world and started of pilot trials with the manufacturer.
2017: Received order for commercial trials of Nitro Derivatives of Isophthalic acid from the largest manufacturer of X-ray contrast media manufacturer in the world.
2017: The name of the company was changed to Arvee Laboratories (India) Limited pursuant to conversion into a public limited company.
2021: Sold its 100% investment in its subsidiary company namely ‘Arvee Speciality Chemicals’ and ceased to be subsidiary of company.

Arvee Laboratories (India) Ltd (ARVEE)

Arvee Laboratories (India) Ltd (ARVEE)

Arvee Laboratories (India) stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Arvee Laboratories - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Arvee Laboratories (India) Ltd FAQs

About Arvee Laboratories (India) Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Arvee Laboratories (India) Ltd (ARVEE)

Arvee Laboratories (India) Ltd (ARVEE)

Arvee Laboratories (India) stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Arvee Laboratories - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Arvee Laboratories (India) Ltd FAQs

What is the share price of Arvee Laboratories?

What is the market cap of Arvee Laboratories?

What is the P/E ratio of Arvee Laboratories?

What is the P/B ratio of Arvee Laboratories?

What is the 52-week high and low of Arvee Laboratories?

What is the TTM revenue of Arvee Laboratories?

Is Arvee Laboratories (India) Ltd a good quality company?

Is Arvee Laboratories (India) Ltd undervalued or overvalued?

Is Arvee Laboratories (India) Ltd a good buy now?

About Arvee Laboratories (India) Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.